Table 1.
Demographic and HPV risk behavior characteristics of women with a history of an abnormal Pap test in the past 12 months participating in a clinical trial (n=640).
| Characteristic | Total | White | Hispanic | Asian | Black | Other |
|---|---|---|---|---|---|---|
| Age (years), n (%) | ||||||
| 18–24 | 68 (10.63) | 40 (10.61) | 13 (11.30) | 1 (2.44) | 12 (12.77) | 2 (15.38) |
| 25–29 | 88 (13.75) | 55 (14.59) | 14 (12.17) | 5 (12.20) | 12 (12.77) | 2 (15.38) |
| 30–34 | 109 (17.03) | 58 (15.38) | 26 (22.61) | 8 (19.51) | 15 (15.96) | 2 (15.38) |
| 35–39 | 94 (14.69) | 49 (13.00) | 22 (19.13) | 5 (12.20) | 16 (17.02) | 2 (15.38) |
| 40–44 | 83 (12.97) | 46 (12.20) | 11 (9.57) | 7 (17.07) | 17 (18.09) | 2 (15.38) |
| 45–49 | 83 (12.97) | 48 (12.73) | 16 (13.91) | 6 (14.63) | 12 (12.77) | 1 (7.69) |
| 50–54 | 53 (8.28) | 32 (8.49) | 7 (6.09) | 7 (17.07) | 6 (6.38) | 1 (7.69) |
| 55+ | 62 (9.69) | 49 (13.00) | 6 (5.22) | 2 (4.88) | 4 (4.26) | 1 (7.69) |
| Self-reported Race/Ethnicity, n (%) | ||||||
| White | 377 (58.91) | |||||
| Hispanic | 115 (17.97) | |||||
| Asian | 41 (6.41) | |||||
| Black | 94 (14.69) | |||||
| Other/Mixed | 13 (2.03) | |||||
| Birthplace | ||||||
| United States | 410 (64.06) | 260 (68.97) | 57 (49.57) | 2 (4.88) | 86 (91.49) | 5 (38.46) |
| Canada | 94 (14.69) | 91 (24.14) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 3 (23.08) |
| Mexico | 31 (4.84) | 0 (0.00) | 31 (26.96) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
| Central/South America | 29 (4.53) | 2 (0.53) | 27 (23.48) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
| East Asia | 11 (1.72) | 0 (0.00) | 0 (0.00) | 11 (26.83) | 0 (0.00) | 0 (0.00) |
| Other | 63 (9.84) | 22 (5.84) | 0 (0.00) | 28 (68.29) | 8 (8.51) | 5 (38.46) |
| Unknown | 2 (0.31) | 2 (0.53) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
| History of Tobacco Use, n (%) | ||||||
| Yes | 255 (39.84) | 193 (51.19) | 32 (27.83) | 4 (9.76) | 18 (19.15) | 8 (61.54) |
| No | 384 (60.00) | 183 (48.54) | 83 (72.17) | 37 (90.24) | 76 (80.85) | 5 (38.46) |
| Unknown | 1 (0.16) | 1 (0.27) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
| Age of Sexual Debut (median years; range) | 17 (4–37) | 17 (4–37) | 18 (7–30) | 23 (15–34) | 17 (7–35) | 18 (13–21) |
| Lifetime Sexual Partners, n (%) | ||||||
| 0–2 | 163 (25.47) | 76 (20.16) | 46 (40.00) | 26 (63.41) | 12 (12.77) | 3 (23.08) |
| 3–4 | 115 (17.97) | 61 (16.18) | 29 (25.22) | 6 (14.63) | 18 (19.15) | 1 (7.69) |
| 5–9 | 178 (27.81) | 107 (28.38) | 28 (24.35) | 5 (12.20) | 34 (36.17) | 4 (30.77) |
| 10 or More | 149 (23.28) | 112 (29.71) | 9 (7.83) | 3 (7.32) | 21 (22.34) | 4 (30.77) |
| Unknown | 35 (5.47) | 21 (5.57) | 3 (2.61) | 1 (2.44) | 9 (9.57) | 1 (7.69) |
| HPV 16 & 18 DNA, n (%) | ||||||
| HPV 16+ | 290 (45.31) | 184 (48.81) | 42 (36.52) | 25 (60.98) | 32 (34.02) | 7 (53.85) |
| HPV 18+ | 74 (11.56) | 43 (11.41) | 9 (7.83) | 3 (7.32) | 17 (18.09) | 2 (15.38) |
| HPV 16+ and 18+ | 106 (16.56) | 65 (17.24) | 21 (18.26) | 4 (9.76) | 14 (14.89) | 2 (15.38) |
| Negative for HPV 16+ or 18+ | 170 (26.56) | 85 (22.55) | 43 (37.39) | 9 (21.95) | 31 (32.98) | 2 (15.38) |
| Cervical Dysplasia, n (%) | ||||||
| Negative for Dysplasia | 190 (29.69) | |||||
| ≤CIN1 | 292 (45.63) | |||||
| ≥CIN2 | 137 (21.41) | |||||
| No Diagnosis Possible | 13 (2.03) | |||||
| Unknown | 8 (1.25) |